How should I manage a patient with diarrhea and an elevated fecal calprotectin of 192 µg/g?

Management of Diarrhea with Fecal Calprotectin 192 µg/g

A fecal calprotectin of 192 µg/g indicates significant intestinal inflammation and warrants colonoscopy with biopsies to establish the diagnosis and guide treatment, after first excluding infectious causes. 1, 2

Immediate Diagnostic Steps

Rule Out Infection First

• Test stool for Clostridioides difficile and other enteric pathogens before attributing symptoms to inflammatory bowel disease, as infections can elevate fecal calprotectin and mimic IBD. 1, 2
• Bacterial pathogens (Salmonella, Campylobacter) produce markedly elevated calprotectin levels (median 689-765 µg/g), while viral infections (rotavirus, norovirus) typically show lower levels (median 89-95 µg/g). 3
• Fecal calprotectin >100 µg/g has 67% sensitivity and 75% specificity for microscopic colitis in patients with chronic watery diarrhea. 4

Proceed to Endoscopic Evaluation

• Perform colonoscopy with segmental biopsies throughout the colon to confirm diagnosis, define disease extent, and obtain histology. 1
• At a calprotectin level of 192 µg/g (above the 150 µg/g threshold), the sensitivity for detecting moderate-to-severe endoscopic inflammation is 71% with specificity of 69%. 5
• Endoscopic appearance alone may underestimate true disease extent; segmental biopsies are required even in normal-appearing mucosa. 1
• Obtain baseline labs: complete blood count, C-reactive protein, albumin, and erythrocyte sedimentation rate to assess systemic inflammation. 1

Interpretation of the 192 µg/g Level

Diagnostic Thresholds

• Your patient's calprotectin of 192 µg/g falls between the 150 µg/g and 250 µg/g cutoffs used in IBD guidelines. 5, 6
• At the 150 µg/g threshold, approximately 4.3% of patients may be falsely reassured (false negative rate) when they actually have moderate-to-severe endoscopic activity. 5
• This level strongly suggests organic inflammatory disease rather than functional bowel disorder, with fecal calprotectin demonstrating superior discrimination compared to fecal hemoglobin for detecting colorectal inflammation. 7

Clinical Context Matters

• In symptomatic patients with active diarrhea, calprotectin >150 µg/g can confirm active inflammation and guide treatment decisions. 2
• In patients with known IBD who are in symptomatic remission, calprotectin >150 µg/g should prompt endoscopic assessment rather than empiric treatment escalation. 2
• For new-onset diarrhea with calprotectin 192 µg/g, colonoscopy is mandatory to establish the diagnosis. 1, 2

Common Pitfalls to Avoid

Do Not Delay Endoscopy

• Do not rely solely on fecal calprotectin for diagnosis or treatment decisions without endoscopic confirmation, especially at intermediate levels like 192 µg/g. 1
• Approximately 20-26% of asymptomatic individuals with endoscopic remission may show elevated calprotectin (false positives). 2

Consider Alternative Diagnoses

• Microscopic colitis should be considered, particularly in women over 60 years with chronic watery diarrhea, as it can present with elevated calprotectin despite normal-appearing mucosa. 4, 8
• Age >60 years (OR 3.8) and calprotectin levels >100 µg/g (OR 5.3) are independently associated with microscopic colitis risk. 4
• Colorectal cancer and other inflammatory conditions can also elevate calprotectin. 9

Recognize Disease Extent Implications

• If ulcerative colitis is diagnosed, approximately 50% of patients initially presenting with isolated proctitis will develop more extensive disease over time, making complete colonoscopy essential rather than flexible sigmoidoscopy alone. 1

Post-Diagnosis Management Framework

If IBD is Confirmed

• Initiate treatment based on disease extent and severity documented at colonoscopy. 1
• For ulcerative proctitis: start mesalamine 1 g rectal suppository once daily, with consideration for adding oral mesalamine given the elevated calprotectin >150 mg/g. 1
• Recheck fecal calprotectin at 3 months to evaluate treatment response; target <50 mg/g for confirming endoscopic improvement. 1, 2
• Perform endoscopic reassessment at 3-6 months to document mucosal healing. 1

If Microscopic Colitis is Confirmed

• Monitor fecal calprotectin levels frequently, as high concentrations increase the risk of diarrhea flare-ups. 8
• Consider budesonide or loperamide based on disease severity and symptom burden. 8